Archive: News
-
MDP In The News: DMV Alzheimer’s caregiver and researcher present hopeful insights in fight with dementia MDP in the news
7 News' Adrianna Hopkins sat down with a former memory loss caregiver and a lead researcher at Georgetown University’s Memory Disorders Program for insight. Click Here for access to the full arti
Category: News
-
The Northern Virginia Dementia Care Consortium’s 37TH ANNUAL CAREGIVER’S CONFERENCE : November 10, 2023
When Caregiving Calls:Building a Framework for ResilienceNovember 10, 2023 from 8:00 am - 3:30 pm Korean Central Presbyterian Church,15451 Lee Highway Centreville, VA 20121The Northern Virginia De
-
Rock For Research- An Alzheimer’s Event
5-9PM on September 24th. Price of Admission is a suggested $100 donation per person ages 15 and up. Donate here to attend!
Category: News
-
Looking for a Breakthrough in Alzheimer’s Disease
Lara Stefansson is a PhD student in neuroscience and a trainee in Georgetown’s Pharmacological Sciences Training Program. See her article from 6 April 2023 on Alzheimer's treatments, understanding
Category: News
-
Treatment with solanezumab is not effective in preventing Alzheimer’s disease
Katie Seidenberg and R. Scott Turner Eli Lilly and collaborators released the topline results of the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s disease (A4) Study March 8th (NCT02008357 on
Category: News
-
Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner
R. Scott Turner A breakthrough, finally! Leqembi is the first disease-modifying treatment for individuals with MCI and mild AD with solid evidence of effectiveness. Thus, Leqembi (previously calle
Category: News
-
MDP in the News
The Memory Disorders Program's own Clinical Trial Manager, Angelica Forero, was interviewed about a groundbreaking clinical trial at Georgetown using 'nicotine' to end memory loss. See the full artic
Category: News
-
Allegations of fraud in Alzheimer’s disease research- death of the amyloid hypothesis?
R. Scott Turner, PhD, MD Recent reports of fraud in Alzheimer’s disease (AD) research have raised major concerns. Some of the figures in a highly-cited paper (using animal models of AD) published
Category: News
-
These Simple Tasks Can Cut Your Risk Of Dementia, Study Finds
29 JULY 2022: Link to Huffington Post article
Category: News
-
Achieving Greater Diversity in Dementia Research: A Call to Action
by R. Scott Turner and Charlyn Gomez: In the US, individuals in URGs are defined as Black or African-American, Hispanic/Latinx, Indigenous and Native American, Asian, Native Hawaiians and other P
Category: News